The legacy of Viagra and its parent , copyright, presents a complex picture for potential investors. While the revolutionary drug initially generated enormous revenues , click here its protection has lapsed , leading to rival alternatives flooding the landscape . This decline in pricing presents a real challenge for copyright and any fund consideri